DIVA Laboratories Ltd (4153) — Cash Flow Reinvestment Rate
DIVA Laboratories Ltd (4153) has a Cash Flow Reinvestment Rate of 0.04x as of December 2025, reinvesting NT$241.00K (capex NT$241.00K ) from operating cash flow of NT$5.57 Million. See 4153 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
DIVA Laboratories Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for DIVA Laboratories Ltd across 7 annual periods. For the full cash flow conversion analysis, see 4153 cash flow conversion.
Annual Cash Flow Reinvestment Rate for DIVA Laboratories Ltd (2017–2025)
Year-by-year capital reinvestment analysis for DIVA Laboratories Ltd. See financial agility of DIVA Laboratories Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | NT$1.00 Million | NT$20.77 Million | NT$1.00 Million | ▲ +178.2% |
| 2024 | 0.02x | NT$2.13 Million | NT$123.14 Million | NT$2.13 Million | ▼ -43.1% |
| 2023 | 0.03x | NT$7.69 Million | NT$252.91 Million | NT$7.69 Million | ▼ -86.5% |
| 2022 | 0.22x | NT$16.46 Million | NT$73.19 Million | NT$11.42 Million | ▼ -83.4% |
| 2019 | 1.35x | NT$71.34 Million | NT$52.66 Million | NT$12.79 Million | ▲ +403.6% |
| 2018 | 0.27x | NT$23.14 Million | NT$86.02 Million | NT$21.71 Million | ▼ -81.8% |
| 2017 | 1.48x | NT$61.14 Million | NT$41.45 Million | NT$13.31 Million | — |